Come and visit London’s Home of Trophies. 🏆
Book your Stadium Tour at Stamford Bridge now. ⭐️⭐Come and visit London’s Home of Trophies. 🏆
Book your Stadium Tour at Stamford Bridge now. ⭐️⭐Come and visit London’s Home of Trophies. 🏆
Book your Stadium Tour at Stamford Bridge now. ⭐️⭐Come and visit London’s Home of Trophies. 🏆
Book your Stadium Tour at Stamford Bridge now. ⭐️⭐Come and visit London’s Home of Trophies. 🏆
Book your Stadium Tour at Stamford Bridge now. ⭐️⭐Come and visit London’s Home of Trophies. 🏆
Book your Stadium Tour at Stamford Bridge now. ⭐️⭐️
She was my very first colorectal cancer patient 5 years ago, who received dual immunotherapy despite her tumor not primarily classifying for immunotherapy.
Her cancer had spread to the lungs without any options to perform surgery. She had gone through various cycles of chemo with no meaningful effect in the end.
But her tumor showed a high reading of another marker called TMB - tumor mutational burden.
✅ After 3 cycles of immunotherapy all the lung metastases were gone and she remains with no evidence of disease until today. A tremendous success story of modern personalized oncology.
Stage 3 rectal cancer in a 26 year old. This is what I've been warning about. The incidence of colorectal cancer in young adults has nearly doubled since the early 1990s. We're seeing Stage III and IV in people under 40 with increasing aggressiveness.
But the real story here is the treatment. This is dostarlimab, a PD-1 checkpoint inhibitor. Immunotherapy alone. No surgery. No chemo. No radiation. 100% clinical complete response rate in mismatch repair deficient rectal cancers. The immune system did what it was designed to do.
We've known since PD-1 inhibitors were approved in 2014 that this was the direction cancer treatment needed to go. The paradigm is shifting. Empower the immune system instead of destroying it.
Dr. Kwabena Frimpong-Boateng from Ghana 🇬🇭 is the first black Doctor to perform a heart transplant in the world in Germany in 1985.
He also performed the first open-heart surgery in Ghana using the heart-lung-machine, helping Ghanaians hearts breath again.
Presented at #AHA25:
Among patients with atherosclerosis or diabetes but no previous myocardial infarction or stroke, evolocumab led to a lower risk of major adverse cardiovascular events than placebo. Full VESALIUS-CV trial results: https://t.co/vAZ9gSjnpZ
Editorial: VESALIUS and the Anatomy of High-Risk Prevention https://t.co/GatRtqyY8v
@AHAScience